posted on 2023-03-31, 00:08authored byYuval Shaked, Elizabeth Pham, Santosh Hariharan, Ksenia Magidey, Ofrat Beyar-Katz, Ping Xu, Shan Man, Florence T.H. Wu, Valeria Miller, David Andrews, Robert S. Kerbel
Levels of viable CEPs in the blood of Balb/c mice treated with escalating doses of capecitabine (S1); A flow chart of the image analysis (S2); Colonization of bone marrow derived cells in tumors from mice treated with LDM or MTD capecitabine regimens with or without LDM CTX assessed by flow cytometry (S3); Apoptosis and necrosis in tumors from mice treated with LDM or MTD capecitabine regimens with or without LDM CTX (S4); Microvessel density in tumors from mice treated with LDM or MTD capecitabine regimens with or without LDM CTX (S5); Liver metastasis in HT-29 bearing mice treated with MTD or LDM capecitabine regimens with or without LDM CTX (S6).